Kucera, Otto
Poslední změna: 16.12. 2013

Nejvýznamnější publikace v časopisech s IF od roku 2006

2006

  • Adamcová M, Štěrba M, Šimůnek T, Potáčová A, Popelová O, Geršl V. Regulatory proteins of the myocardium and heart failure. Eur J Heart Fail. 2006;8(4):333-42. IF=3,242
  • Štěrba M, Popelová O, Šimůnek T, Mazurová Y, Potáčová A, Adamcová M, Kaiserová H, Poňka P, Geršl V. Cardioprotective effects of a novel iron chelator, pyridoxal 2-chlorobenzoyl hydrazone, in the rabbit model of daunorubicin-induced cardiotoxicity. J Pharmacol Exp Ther. 2006;319(3):1336-47. IF=3,956

2007

  • Adamcová M, Šimůnek T, Kaiserová H, Popelová O, Štěrba M, Potáčová A, Vávrová J, Maláková J, Geršl V. In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicity. Toxicology 2007;237(1-3):218-28. IF=2,919
  • Potáčová A, Adamcová M, Čajňáková H, Hrbatová L, Štěrba M, Popelová O, Šimůnek T, Poňka P, Geršl V. Evaluation of ECG time intervals in a rabbit model of anthracycline-induced cardiomyopathy: a useful tool for assessment of cardioprotective agents. Physiol Res. 2007;56(2):251-4. IF=1,505
  • Štěrba M, Popelová O, Šimůnek T, Mazurová Y, Potáčová A, Adamcová M, Gunčová I, Kaiserová H, Palička V, Poňka P, Geršl V. Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH). Toxicology.2007;235(3):150-66. IF=2,919
  • Štěrba M, Šimůnek T, Popelová O, Potáčová A, Adamcová M, Mazurová Y, Holečková M, Geršl V. Early detection of anthracycline cardiotoxicity in a rabbit model: left ventricle filling pattern versus troponin T determination. Physiol Res. 2007;56(5):535-545. IF=1,505
  • Šimko F, Potáčová A, Pelouch V, Paulis L, Matúšková J, Krajčírovičová K, Pecháňová O, Adamcová M. Spontaneous, L-Arginine-Induced and Spironolactone-Induced Regression of Protein Remodeling of the Left Ventricle in L-NAME-Induced Hypertension. Physiol Res. 2007;56(Supl. 2):55-62 IF=1,505

2008

  • Popelová O, Štěrba M, Šimůnek T, Mazurová Y, Gunčová I, Hroch M, Adamcová M, Geršl V. Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo. J Pharmacol Exp Ther. 2008;326(1):259-69. IF=4,309
  • Šimůnek T, Štěrba M, Popelová O, Kaiserová H, Potáčová A, Adamcová M, Mazurová Y, Poňka P, Geršl V. Pyridoxal isonicotinoyl hydrazone (PIH) and its analogs as protectants against anthracycline-induced cardiotoxicity. Hemoglobin 2008;32(1-2):207-215. IF=0,941
  • Šimůnek T, Štěrba M, Popelová O, Kaiserová H, Adamcová M, Hroch M, Hašková P, Poňka P, Geršl V. Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone. Br J Pharmacol. 2008;155(1): 138-48. IF=4,902
  • Paulis L, Matušková J, Adamcová M, Pelouch V, Šimko J, Krajcirovicova K, Potáčová A, Hulin I, Janega P, Pechaňová O, Šimko F. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone. Acta Physiol (Oxf). 2008;194(1):45-55. IF=2,455

2009

  • Paulis L, Pechanová O, Zicha J, Krajcirovicová K, Barta A, Pelouch V, Adamcová M, Šimkova F: Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro-L-arginine-methyl ester hypertensive rats. J Hypertension. 2009;27(suppl. 6):S11-6. IF= 5,132
  • Popelová O, Štěrba M, Hašková P, Šimůnek T, Hroch M, Gunčová I, Nachtigal P, Adamcová M, Geršl V, Mazurová Y. Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomycytes from apoptotic cell death. Br J Cancer. 2009;101:792-802. IF=4,846
  • Šimko F, Pechanová O, Pelouch V, Krajcirovicová K, Mullerová M, Bednářová K, Adamcová M, Paulis L: Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats. J Hypertension. 2009;27(suppl. 6):S5-10. IF= 5,132
  • Šimůnek T, Štěrba M, Popelová O, Adamcová M, Hrdina R., Geršl V. Anthracycline-induced cardiotoxicity: Overview of studies examining the role of oxidative stress and free cellular iron. Pharmacol Rep. 2009;61: 154–171. IF=2,167

2010

  • Adamcová M, Potáčová P, Popelová O, Štěrba M, Mazurová Y, Aupperle H, Geršl V. Cardiac remodeling and MMPs on the model of chronic daunorubicin-induced cardiomyopathy in rabbits. Phys. Res. 2010; 59: 831-836. IF=1,653
  • Simko, Pechanova O, Pelouch V, Krajcirovicova K, Celec P, Palffy R, Bednarova K, Vrankova S, Adamcova M, Paulis L. Continuous light and L-NAME-induced left ventricular remodelling: different protection with melatonin and captopril. J Hypertens. 2010; 28 Suppl 1 S13-S18. IF= 5,132
  • Paulis L, Pechanova O, Zicha J, Liskova S, Celec P, Mullerova M, Kollar J, Behuliak M, Kunes J, Adamcova M, Simko F. Melatonin improves the restoration of endothelium-derived constricting factor signalling and inner diameter in the rat femoral artery after cessation of L-NAME treatment. J Hypertens. 2010; 28 Suppl 1 S19-S24. IF= 5,132
  • Serra M, Papakonstantinou S, Adamcová M, O´Brien PJames. Veterinary and toxicological applications for the detection of cardiac injury using cardiac troponin The Veterinary Journal 2010; 185(1): 50-57. IF = 2,32

2011

  • Adamcová M, Štěrba M, Popelová O, Jirkovský E, Vávrová J, Geršl V. Srdeční troponiny – společná řeč experimentální a klinické kardiologie. Labor Aktuell 2011;1:10-13.
  • Štěrba M, Popelová O, Lenčo J, Fučíková A, Brčáková E, Mazurová Y, Jirkovský E, Šimůnek T, Adamcová M, Mičuda S, Stulík J, Geršl V. Proteomic insights into chronic anthracycline cardiotoxicity. J Mol Cell Cardiol. 2011;50(5):849-62. IF= 5,148.                                                       

2012

  • Jirkovsky E,  Popelova O, Krivakova-Stankova P, Vávrová A, Hroch M, Hašková P, Brčáková-Doleželová E, Mičuda S, Adamcová M, Šimůnek T, Červinková Z, Geršl V, Štěrba M. Chronic Anthracycline Cardiotoxicity: Molecular and Functional Analysis with Focus on Nuclear Factor Erythroid 2-Related Factor 2 and Mitochondrial Biogenesis Pathways.J Pharmacol Exp Ther. 2012; 343 (2): 468-478. IF=3,891.

2013

  • Jirkovsky E, Lencova-Popelova O,  Hroch M, Adamcová M, Mazurová Y, Vávrová A, Mičuda S, Šimůnek T, Geršl V. and Štěrba M. Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits. Toxicology 2013; 311(3):191-204. IF=3,763
  • Adamcová M, Ruzickova S, Simko F. Multiplexed immunoassays for simultaneous quantification of cardiovascular biomarkers in the model of H-G-nitro-L arginine methyester (L-NAME) hypertensive rat. J Physiol Pharmacol 2013; 64(2): 211-217.  IF=2,48. 

Kalendář akcí

<říjen 2019>
poútstčtsone
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
6
7
8
9
10
Dnes: